CONMED Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 25, 2023 at 04:05 pm EDT
Share
CONMED Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 304.58 million compared to USD 275.09 million a year ago. Net income was USD 15.84 million compared to USD 46.15 million a year ago. Basic earnings per share from continuing operations was USD 0.52 compared to USD 1.51 a year ago. Diluted earnings per share from continuing operations was USD 0.5 compared to USD 1.48 a year ago.
For the nine months, sales was USD 917.7 million compared to USD 794.61 million a year ago. Net income was USD 31.39 million compared to net loss of USD 107.17 million a year ago. Basic earnings per share from continuing operations was USD 1.02 compared to basic loss per share from continuing operations of USD 3.59 a year ago. Diluted earnings per share from continuing operations was USD 0.99 compared to diluted loss per share from continuing operations of USD 3.59 a year ago.
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.